Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 7/20 | 0.38 |
| ▸ | CA2 | P00918 | 6/20 | 0.38 |
| ▸ | CA9 | Q16790 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.33 |
| ▸ | CA7 | P43166 | 2/20 | 0.33 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.33 |
| ▸ | CA4 | P22748 | 1/20 | 0.33 |
| ▸ | CA6 | P23280 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24391548 | 0.82 | CA1 (0.32) | CA1CA2CA9 | |
| SCHEMBL1146109 | 0.78 | CA1 (0.33) | CA1CA2CA9CA12CA14 | |
| SCHEMBL819682 | 0.74 | KDM4E (0.36) | CA1 | |
| SCHEMBL1408715 | 0.72 | — | — | |
| SCHEMBL24391724 | 0.69 | CA1 (0.31) | CA1CA2CA9CA12CA14 | |
| SCHEMBL825142 | 0.69 | — | — | |
| Hydrochloric Acid SCHEMBL31663435 | 0.67 | CA1 (0.35) | CA1CA2CA9CA12CA14 | |
| SCHEMBL1145321 | 0.66 | CA12 (0.37) | CA1CA2CA12CA14 | |
| SCHEMBL24571654 | 0.65 | — | — | |
| SCHEMBL43258 | 0.65 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 198 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0270282-A2 | Oleic acid esters and pharmaceutical compositions | H. LUNDBECK A/S (DK) | 1988-06-08 | — | — | EP | claimed |
| WO-2023114615-A1 | OXIDATIVE CYCLIZATION REAGENTS FOR CHEMOSELECTIVE TRYPTOPHAN BIOCONJUGATION | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2023-06-22 | — | — | WO | disclosed |
| US-20220135598-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF | INTEGRAL BIOSCIENCES PRIVATE LIMITED (IN) | 2022-05-05 | — | — | US | disclosed |
| EP-2168181-B1 | MIXTURES FOR PRODUCING PHOTOACTIVE LAYERS FOR ORGANIC SOLAR CELLS AND ORGANIC PHOTODETECTORS | HELIATEK GMBH (DE) | 2021-05-12 | — | — | EP | disclosed |
| EP-2939675-B1 | OCT3 ACTIVITY INHIBITOR CONTAINING IMIDAZOPYRIDINE DERIVATIVE AS ACTIVE COMPONENT, AND OCT3 DETECTION AGENT | SHIN NIPPON BIOMEDICAL LABORATORIES LTD (JP) | 2019-09-04 | — | — | EP | disclosed |
| US-10149840-B2 | OCT3 activity inhibitor containing imidazopyridine derivative as active component, and OCT3 detection agent | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) | 2018-12-11 | — | — | US | disclosed |
| US-20180000797-A1 | OCT3 ACTIVITY INHIBITOR CONTAINING IMIDAZOPYRIDINE DERIVATIVE AS ACTIVE COMPONENT, AND OCT3 DETECTION AGENT | SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. (JP) | 2018-01-04 | — | — | US | disclosed |
| US-9831042-B2 | Organic dyes comprising a hydrazone moiety and their use in dye-sensitized solar cells | BASF SE (DE) | 2017-11-28 | — | — | US | disclosed |
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| US-9758480-B2 | 1-(cycloalkyl-carbonyl)proline derivative | SUMITOMO DAINIPPON PHARMA CO., LTD. (JP) | 2017-09-12 | — | — | US | disclosed |
| EP-0479076-A1 | Process for transfer of indoaniline dyestuffs | BASF Aktiengesellschaft (DE) | 1992-04-08 | — | — | EP | disclosed |
| EP-0467327-A1 | Silver halide color photographic photosensitive material and method of processing same | FUJI PHOTO FILM CO., LTD. (JP) | 1992-01-22 | — | — | EP | disclosed |
| EP-0127162-B1 | COLOR PHOTOGRAPHIC LIGHT-SENSITIVE MATERIAL | FUJI PHOTO FILM CO., LTD. (JP) | 1989-11-15 | — | — | EP | disclosed |
| US-4842985-A | COUPLER HAVING DYE MOIETY WITH SHIFTED MAXIMUM ABSORPTION WAVELENGTH, HUE-FIXING COMPOUND | FUJI PHOTO FILM CO., LTD. (JP) | 1989-06-27 | — | — | US | disclosed |
| EP-0261567-A2 | Heat development process and colour-photographic recording material suitable therefor | Agfa-Gevaert AG (DE) | 1988-03-30 | — | — | EP | disclosed |
| US-4729944-A | NONDIFFUSIBLE COUPLER, IMPROVED GRANINESS AND SENSITIVITY | FUJI PHOTO FILM CO., LTD. (JP) | 1988-03-08 | — | — | US | disclosed |
| US-4705743-A | NONDIFFUSING COUPLER | FUJI PHOTO FILM CO. LTD. (JP) | 1987-11-10 | — | — | US | disclosed |
| US-4585728-A | 2-EQUIVALENT MAGENTA COUPLER AND AMINE | FUJI PHOTO FILM CO., LTD. (JP) | 1986-04-29 | — | — | US | disclosed |
| US-4555479-A | CONTAINING 5-PYRAZOLONE TYPE MAGENTA COUPLERS AND NITROGEN COMPOUND-PREVENTION STAINING | FUJI PHOTO FILM CO., LTD. (JP) | 1985-11-26 | — | — | US | disclosed |
| EP-0127162-A2 | Color photographic light-sensitive material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-12-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10149840-B2 | OCT3 activity inhibitor containing imidazopyridine derivative as active component, and OCT3 detection agent | SLCO1B3, SLC22A8, SLCO4C1 | CA1 3148/4885CA2 377/4885CA9 695/4885 |
| US-20180000797-A1 | OCT3 ACTIVITY INHIBITOR CONTAINING IMIDAZOPYRIDINE DERIVATIVE AS ACTIVE COMPONENT, AND OCT3 DETECTION AGENT | SLCO1B3, SLC22A8, SLCO4C1 | CA1 3148/4885CA2 377/4885CA9 695/4885 |
| US-20220135598-A1 | ECTONUCLEOTIDE PYROPHOSPHATASE-PHOSPHODIESTERASE-1 (ENPP1) INHIBITORS AND USES THEREOF | ENPP1, ENPP3, ENPP2 | CA1 4424/4885CA2 2645/4885CA9 2755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.